Last reviewed · How we verify

NCT06290011

A Clinical Study on the Efficacy of Cognitive Distraction Focus Relaxation Therapy Based on MR

Recruiting now Last updated 13 November 2024
What this trial tests

trial testing Pain key group in Pain in 132 participants. Currently enrolling.

Timeline
11 October 2023
Primary endpoint
11 June 2025
11 June 2025

Quick facts

Lead sponsorXinhua Hospital, Shanghai Jiao Tong University School of Medicine
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment132
Start date11 October 2023
Primary completion11 June 2025
Estimated completion11 June 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Who can join

Adults 18 to 85, any sex, with Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective, single blind, randomized, parallel controlled trial was conducted to evaluate the analgesic effect and safety of MR based "cognitive distraction focus relaxation therapy" in patients clinically diagnosed with chronic moderate to severe pain

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Xinhua Hospital, Shanghai Jiao Tong University School of Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06290011.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing